BRPI0610123A2 - composição farmacêutica, kit e utilização de uma composição - Google Patents

composição farmacêutica, kit e utilização de uma composição Download PDF

Info

Publication number
BRPI0610123A2
BRPI0610123A2 BRPI0610123-2A BRPI0610123A BRPI0610123A2 BR PI0610123 A2 BRPI0610123 A2 BR PI0610123A2 BR PI0610123 A BRPI0610123 A BR PI0610123A BR PI0610123 A2 BRPI0610123 A2 BR PI0610123A2
Authority
BR
Brazil
Prior art keywords
therapeutically active
active substance
antitumor
agents
mixtures
Prior art date
Application number
BRPI0610123-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Remmal Adnane
Original Assignee
Advanced Scientific Developments
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scientific Developments filed Critical Advanced Scientific Developments
Publication of BRPI0610123A2 publication Critical patent/BRPI0610123A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0610123-2A 2005-05-13 2006-05-15 composição farmacêutica, kit e utilização de uma composição BRPI0610123A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB2005/001314 WO2006120495A1 (fr) 2005-05-13 2005-05-13 Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
IBPCT/IB2005/001314 2005-05-13
PCT/IB2006/001328 WO2006120564A1 (fr) 2005-05-13 2006-05-15 Composition pharmaceutique comprenant un antiviral , un antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol , le thymol, l' eugenol, le borneol et le carvacrol

Publications (1)

Publication Number Publication Date
BRPI0610123A2 true BRPI0610123A2 (pt) 2012-09-25

Family

ID=35427309

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0610123-2A BRPI0610123A2 (pt) 2005-05-13 2006-05-15 composição farmacêutica, kit e utilização de uma composição
BRPI0610130-5A BRPI0610130A2 (pt) 2005-05-13 2006-05-15 composição farmacêutica, kit e utilização de uma composição

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0610130-5A BRPI0610130A2 (pt) 2005-05-13 2006-05-15 composição farmacêutica, kit e utilização de uma composição

Country Status (16)

Country Link
US (2) US20080171768A1 (https=)
EP (2) EP1879656B1 (https=)
JP (1) JP5073651B2 (https=)
CN (2) CN101175532B (https=)
AP (1) AP2437A (https=)
AT (1) ATE554827T1 (https=)
BR (2) BRPI0610123A2 (https=)
CA (2) CA2608061C (https=)
DK (2) DK1883452T3 (https=)
EA (1) EA015168B1 (https=)
ES (2) ES2386292T3 (https=)
MA (2) MA29573B1 (https=)
PT (2) PT1883452E (https=)
TN (2) TNSN07423A1 (https=)
WO (3) WO2006120495A1 (https=)
ZA (1) ZA200710785B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113042A1 (en) * 2006-09-05 2008-05-15 Chu Kee Hung Pharmaceutical composition and method for cancer treatment based on combinational use of conventional anticancer agents and geranium oil or compounds thereof
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
AU2010297406B2 (en) 2009-09-24 2013-10-17 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
WO2012076310A1 (en) 2010-12-07 2012-06-14 Unilever Nv An oral care composition
MX2014005405A (es) 2011-11-03 2014-06-23 Unilever Nv Una composicion de limpieza personal.
CN102579449B (zh) * 2012-03-30 2013-08-07 厦门大学 一种可提高肿瘤对紫杉醇敏感性的联合用药
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
CN107405404A (zh) * 2015-03-20 2017-11-28 塞米·欧尤·奥皮约 苏拉明和精氨酸酶抑制剂在恶性肿瘤中的用途
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
CN105147647A (zh) * 2015-08-19 2015-12-16 华南理工大学 右旋龙脑作为抗肿瘤药物增敏剂的应用
WO2017209588A2 (fr) 2016-06-02 2017-12-07 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
CA3057858A1 (en) * 2017-03-28 2018-10-04 IRP Health Pty Ltd Berberine alkaloids in the prevention and/or treatment of intestinal disease
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
CN112972437B (zh) * 2021-02-19 2022-03-25 沈阳伟嘉生物技术有限公司 一种包含碘硝酚的长效外用制剂及其制备方法和用途
CN121550195A (zh) * 2026-01-21 2026-02-24 哈尔滨医科大学 β-紫罗兰酮在制备肿瘤免疫调节剂中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE19509697A1 (de) * 1995-03-08 1996-09-12 Schering Ag Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US20020182268A1 (en) * 1998-12-07 2002-12-05 Bessette Steven M. Cancer treatment compositions and method using natural plant essential oils
US6536268B1 (en) * 1999-11-01 2003-03-25 Siemens Vdo Automotive Corporation Utilizing increasing width for identification voltages
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
US20050014827A1 (en) * 2000-11-09 2005-01-20 Schur Jorg P. Synergistic medicament containing flavoring agents and having an antagonistic regenerative and/or protagonist decontamination effect
WO2002053138A2 (en) * 2001-01-02 2002-07-11 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
ATE478684T1 (de) * 2002-02-20 2010-09-15 Ninkov Dusan Dr Antimikrobielle therapeutische zusammensetzungen und ihre verwendung
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
EA200500804A1 (ru) * 2002-12-10 2005-12-29 Биосинексус Инкорпорейтед Топические противоинфекционные композиции
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物

Also Published As

Publication number Publication date
EA200702486A1 (ru) 2008-06-30
TNSN07426A1 (fr) 2009-03-17
PT1883452E (pt) 2013-02-18
TNSN07423A1 (fr) 2009-03-17
DK1883452T3 (da) 2013-02-25
MA29573B1 (fr) 2008-06-02
US20080171709A1 (en) 2008-07-17
ES2399348T3 (es) 2013-03-27
WO2006120564A1 (fr) 2006-11-16
CN101193682A (zh) 2008-06-04
CN101193682B (zh) 2012-06-13
ES2386292T3 (es) 2012-08-16
CA2606887C (fr) 2014-07-15
EA015168B1 (ru) 2011-06-30
CN101175532A (zh) 2008-05-07
EP1879656B1 (fr) 2012-04-25
DK1879656T3 (da) 2012-07-23
CA2608061A1 (fr) 2006-11-16
JP5073651B2 (ja) 2012-11-14
WO2006120495A1 (fr) 2006-11-16
CA2606887A1 (fr) 2006-11-16
AP2437A (en) 2012-08-31
AP2007004228A0 (en) 2007-12-31
US20080171768A1 (en) 2008-07-17
EP1883452A2 (fr) 2008-02-06
JP2008540505A (ja) 2008-11-20
PT1879656E (pt) 2012-07-25
ATE554827T1 (de) 2012-05-15
EP1879656A1 (fr) 2008-01-23
CN101175532B (zh) 2011-12-28
EP1883452B1 (fr) 2012-12-19
CA2608061C (fr) 2014-07-15
WO2006120568A2 (fr) 2006-11-16
WO2006120568A3 (fr) 2007-08-23
MA29908B1 (fr) 2008-11-03
ZA200710785B (en) 2009-06-24
BRPI0610130A2 (pt) 2012-09-25

Similar Documents

Publication Publication Date Title
BRPI0610123A2 (pt) composição farmacêutica, kit e utilização de uma composição
Kris et al. Improved control of cisplatin‐induced emesis with high‐dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients
ES2258566T3 (es) Combinaciones de farmacos (por ejemplo, clorpromacina y pentamidina) para el tratamiento de trastornos neoplasicos.
ES2409755T3 (es) Método para Tratar el Cáncer Utilizando un Agente Anticanceroso Combinado
ES2690061T3 (es) Composiciones para tratar la enfermedad de Parkinson
ES2627020T3 (es) Composición farmacéutica que comprende un inhibidor de HDAC y un esteroide y el uso de la misma
WO2014018563A2 (en) Methods for the treatment of cancer
BRPI0611322A2 (pt) métodos e composicões para controlar distúrbios psicóticos
BR122017028566B1 (pt) Uso de pm01183, ou um sal farmaceuticamente aceitável do mesmo, em combinação sinérgica com um antibiótico anticâncer e kit
JP2016519684A (ja) 準最適に投与された薬物療法の有効性を改善するための及び／又は副作用を低減するための方法および組成物
BR112012030658A2 (pt) formas de dosagem oral de bendamustina e uso terapêutico da mesma
ES2913119T3 (es) Cerdulatinib para tratar mieloma
CN114831931B (zh) 一种具有抗肿瘤增效减毒效果的药用溶液及包含其的药用组合物
BRPI0710085B1 (pt) composições oftálmicas e seus kits
WO2021202245A1 (en) Viral treatment regimens
Wang et al. α-Lipoic acid prevents bupivacaine-induced neuron injury in vitro through a PI3K/Akt-dependent mechanism
ES2441593T3 (es) Composiciones para estimular la actividad de terapias anticáncer
ES2344677T3 (es) Medicamentos para enfermedades articulares.
BR112021011964A2 (pt) Terapias de combinação tripla para antienvelhecimento
BRPI0610132A2 (pt) composição farmacêutica, kit e utilização de uma composição
ES2889404T3 (es) Uso del ginsenósido M1 para la fabricación de un medicamento para el tratamiento del cáncer oral
ES2643167T3 (es) Procedimiento de producción y uso de un copolímero de carboximetilcelulosa sódica y gosipol
ES2396976T3 (es) Método y composición para tratar osteoartritis
BRPI0816364B1 (pt) solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção
Gosland et al. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B15K Others concerning applications: alteration of classification

Ipc: A61K 45/06 (2006.01), A61P 31/12 (2006.01), A61P 3

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL